Healthcare & Life Sciences Insights
Discover Latham’s latest insights into the commercial, regulatory, and legal developments shaping the global healthcare and life sciences landscape.
Trending Topics
Featured Insights
Our Work
Latham Advises Notion Capital on TERN Group’s US$24 Million Series A
Latham & Watkins Advises Avidity Biosciences on Upsized US$600 Million Public Offering of Common Stock
Recognition
Latham Recognized With Six LMG Life Sciences Americas Awards Including Life Cycle Firm of the Year
Honors also include FDA Litigation & Enforcement Firm of the Year, Impact Case of the Year, and Impact Deal of the Year.
Litigation Departments of the Year Finalist — Intellectual Property: Latham & Watkins
Latham's Intellectual Property Litigation Practice was honored for securing exceptional trial results this year, including a complete jury trial win for Sarepta Therapeutics and an ITC trial win for Netgear.
Litigator of the Week Runners-Up and Shout-Outs — Cendyn and ChemoCentryx (Amgen)
A Latham antitrust and appellate litigation team secured a landmark affirmance in an algorithmic pricing dispute. A separate litigation team secured a total summary judgment victory in a securities class action dispute.